91%
Finnrick rating
#4 of 250 Retatrutide vendors
14 of 14 classifiable tests passed
natural 100% · customers 3.8★ (29)
methodology · Purity focus
Finnrick analysis · Retatrutide

Batch documentation is the caveat in Chimera Peptides' retatrutide record: results form a steady clean streak for identity, 99.6–99.9% purity, and fills within the purity-focus range. Most tests lack batch IDs, and one vial ran +24%.

methodology →
vendor intelligence report
Vendor Intelligence Report: Chimera Peptides

Corporate filings, a clientHold legacy domain, and a shared live-chat key complicate Chimera’s public identity. The report also maps the US-order alert, April fulfillment complaints, restrictive payment terms, and a deleted X post.

26 pages7 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutideselected
$1.00
91%
14
2
Tirzepatide
$0.65
83%
9
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%13 Oct 2025: 76%5 Dec 2025: 76%29 Dec 2025: 79%29 Dec 2025: 80%22 Jan 2026: 82%20 Feb 2026: 84%22 Feb 2026: 85%16 Mar 2026: 86%27 Apr 2026: 87%28 Apr 2026: 88%25 May 2026: 89%5 Aug 2026: 89%5 Aug 2026: 90%5 Aug 2026: 91%9 Aug 2026: current 91%76%84%91%Oct 25Aug 26
Showing Retatrutide tests only
Chimera Peptides Retatrutide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
5 Aug 2026Pass
Tested
lab nameView COA
5 Aug 2026Pass
Tested
lab nameView COA
5 Aug 2026Pass
Tested
lab nameView COA
25 May 2026Pass
Tested
lab nameView COA
28 Apr 2026Pass
Tested
lab nameView COA
27 Apr 2026Pass
Tested
lab nameView COA
16 Mar 2026Pass
Tested
lab nameView COA
22 Feb 2026Pass
Tested
lab nameView COA
20 Feb 2026Pass
Tested
lab nameView COA
22 Jan 2026Pass
Tested
lab nameView COA
1-10 of 14

About Chimera Peptides test results from Finnrick

Chimera Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 23 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Chimera Peptides peptides in this dataset are Retatrutide (14 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 23 recent tests.

Corrections
No corrections.